Another Melanoma Treatment Approved

There was suprising news today. While everyone expected the drug to be approved, it was done early. This announcement brings joy to a melanoma survivor, but I also can't help remembering my friend Amy who lost her fight earlier this year.

Zelboraf is the second melanoma drug to be approved by the FDA this year and the first therapy approved that targets a specific gene mutation. The FDA’s announcement follows the March approval of Bristol-Myers Squibb’s Yervoy, a therapy designed to stimulate a person’s immune system to attack the cancer. Prior to 2011, the FDA had not approved a new melanoma treatment in 13 years.

For the article: www.melanoma.org/learn-m
ore/first-gene-targeted-dr
ug-melanoma-approved-fda

Amy was involved in many clinical trials along the way in hopes of finding a treatment-but they were too late for her. I know she is smiling up there that progress has been made-and that someone will benefit from this news.

Previous article on Amy:
www.sparkpeople.com/mypa
ge_public_journal_individu
al.asp?blog_id=4249877